LCD L39832: Botulinum Toxin Injections — NGS
Policy LCD-L39832 · Pain Management
New LCD on Botulinum Toxin Injections impacts billing.
Code intelligence
R20.2 reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code R20.2.
Elevated code riskView ICD-10 detail
Signal breakdown
5 shown · 5 total in platform
Risk: Elevated
0
Critical
0%
2
High
40%
3
Routine
60%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
High
LCD L34624: Somatosensory Testing — WPS
Policy LCD-L34624 · Neurology
Important changes in billing for Somatosensory Testing.
Proposed LCD DL39832: Botulinum Toxin Injections — NGS
Policy LCD-DL39832 · Multi-specialty
Proposed LCD for Botulinum Toxin Injections requires review.
LCD L34623: Intraoperative Neurophysiological Testing — WPS
Policy LCD-L34623 · Neurology
New LCD impacts billing for neurophysiological tests.
LCD L38809: Botulinum Toxins — Novitas
Policy LCD-L38809 · Pain Management
Prepare for Novitas' LCD on Botulinum Toxins effective 11/09/2025.
Audit documentation
Building an audit file that includes R20.2?
The Tripwire Audit Pack exports 12 months of Pain Management policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Pain Management audit pack — $349One-time purchase · not a subscription